选择性5-羟色胺再摄取抑制剂对成人抑郁症患者量表评估自杀意念的影响
该研究对参与舍曲林、帕罗西汀或西酞普兰工业资助研究的成人抑郁症患者进行患者水平合并分析,比较SSRI组(n=5681)与安慰剂组(n=2581)的HRSD自杀意念条目评分。结果显示,25岁及以上成人中SSRI从第1周起降低自杀意念评分并减少恶化风险,而18-24岁年轻成人中SSRI相对安慰剂既未降低也未增加自杀意念评分。
要点
- 25岁及以上成人使用SSRI从第1周起自杀意念评分降低更明显且恶化风险更低。
- 18-24岁年轻成人中SSRI相对安慰剂对自杀意念评分无净效应。
- 研究基于HRSD自杀意念条目的患者水平合并分析,非独立临床终点。
核心结论
- SSRI对24岁以上抑郁症患者自杀意念的净效应似乎有益,对18-24岁患者为中性。
研究设计与样本
- 对参与舍曲林、帕罗西汀或西酞普兰工业资助研究的成人抑郁症患者进行患者水平合并分析。
- 比较SSRI组(n=5681)与安慰剂组(n=2581)的HRSD自杀意念评分。
- 分别分析年轻成人(18-24岁;n=537)和成人(≥25岁;n=7725)。
主要发现
- 在成人中,SSRI组从第1周起自杀意念平均评分降低幅度更大且恶化风险更低。
- 在年轻成人中,SSRI治疗相对安慰剂在终点时既未降低也未增加自杀意念评分。
临床怎么用
- 对25岁及以上抑郁症患者,SSRI治疗对自杀意念的净效应可能有益。
- 对18-24岁年轻成人,SSRI对自杀意念的净效应为中性,仍需常规监测。
局限性
- 研究基于工业资助的舍曲林、帕罗西汀或西酞普兰研究,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) have been claimed to elicit or aggravate suicidal ideation. Aims To explore the effect of SSRIs on the suicidality item of the Hamilton Rating Scale for Depression (HRSD). METHOD: We undertook a patient-level mega-analysis of adults with depression participating in industry-sponsored studies of sertraline, paroxetine or citalopram, comparing patients on an SSRI (n = 5681) with those on placebo (n = 2581) with respect to HRSD-rated suicidality. Separate analyses were conducted for young adults (age 18-24; n = 537) and adults (age ≥25; n = 7725). RESULTS: Among adults, the reduction in mean rating of suicidality was larger and the risk for aggravation of suicidality lower in patients receiving an SSRI from week 1 and onwards. In young adults, SSRI treatment neither reduced nor increased suicidality ratings relative to placebo at the end-point. CONCLUSIONS: The net effect of SSRIs on suicidality appears beneficial in people above the age of 24 and neutral in those aged 18-24. Declaration of interest F.H. has received speaker's fees from Servier. E.E. has previously been on the advisory boards and/or received speaker's honoraria and/or research grants from Eli Lilly, GlaxoSmithKline, Servier and Lundbeck.
引用
- Näslund J, Hieronymus F, Lisinski A, et al. Effects of selective serotonin reuptake inhibitors on rating-scale-assessed suicidality in adults with depression. Br J Psychiatry. 2018. PMID: 29436321. doi:10.1192/bjp.2017.24
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。